Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD

被引：330

作者：

Kuriyan, Ajay E. ^{[1
,3
]}

Albini, Thomas A. ^{[1
]}

Townsend, Justin H. ^{[1
]}

Rodriguez, Marianeli ^{[1
]}

Pandya, Hemang K. ^{[4
]}

Leonard, Robert E., II ^{[4
]}

Parrott, M. Brandon ^{[2
]}

Rosenfeld, Philip J. ^{[1
]}

Flynn, Harry W., Jr. ^{[1
]}

Goldberg, Jeffrey L. ^{[5
]}

机构：

[1] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA

[2] Ctr Sight, Sarasota, FL USA

[3] Univ Rochester, Med Ctr, Dept Ophthalmol, Flaum Eye Inst, Rochester, NY 14642 USA

[4] Univ Oklahoma, Dept Ophthalmol, Dean McGee Eye Inst, Oklahoma City, OK USA

[5] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 11期

基金：

美国国家卫生研究院;

关键词：

IN-VITRO DIFFERENTIATION; OPTIC-NERVE DISEASES; MACULAR DEGENERATION; OPHTHALMOLOGY TREATMENT; CLINICS; INTERVENTIONS; FDA; THERAPIES; SCOTS;

D O I：

10.1056/NEJMoa1609583

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Adipose tissue-derived "stem cells"have been increasingly used by "stem-cell clinics" in the United States and elsewhere to treat a variety of disorders. We evaluated three patients in whom severe bilateral visual loss developed after they received intravitreal injections of autologous adipose tissue-derived "stem cells"at one such clinic in the United States. In these three patients, the last documented visual acuity on the Snellen eye chart before the injection ranged from 20/30 to 20/200. The patients' severe visual loss after the injection was associated with ocular hypertension, hemorrhagic retinopathy, vitreous hemorrhage, combined traction and rhegmatogenous retinal detachment, or lens dislocation. After 1 year, the patients' visual acuity ranged from 20/200 to no light perception.

引用

页码：1047 / 1053

页数：7

共 24 条

[1] Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies
Ambati, J
Ambati, BK
Yoo, SH
Ianchulev, S
Adamis, AP
[J]. SURVEY OF OPHTHALMOLOGY, 2003, 48 (03) : 257 - 293
[2] Responsibilities of Health Care Professionals in Counseling and Educating PatientsWith Incurable Neurological Diseases Regarding "Stem Cell Tourism" Caveat Emptor
Bowman, Michelle
Racke, Michael
Kissel, John
Imitola, Jaime
[J]. JAMA NEUROLOGY, 2015, 72 (11) : 1342 - 1345
[3] Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
Falavarjani, K. Ghasemi
Nguyen, Q. D.
[J]. EYE, 2013, 27 (07) : 787 - 794
[4] Francis PJ, 2010, INVEST OPHTH VIS SCI, V51
[5] Ho AC, 2015, ANG EX DEG 2015 C MI
[6] A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No. 8
Kassoff, A
Kassoff, J
Buehler, J
Eglow, M
Kaufman, F
Mehu, M
Kieval, S
Mairs, M
Graig, B
Quattrocchi, A
Jones, D
Locatelli, J
Ruby, A
Capone, A
Garretson, B
Hassan, T
Trese, MT
Williams, GA
Regan, V
Manatrey, P
Streasick, P
Szydlowski, L
McIver, F
Bridges, C
Stanley, C
Cumming, K
Lewis, B
Zajechowski, M
Margherio, RR
Cox, MS
Camille, J
Falk, R
Siedlak, P
Neubert, C
Klein, ML
Stout, JT
O'Malley, A
Lauer, AK
Robertson, JE
Wilson, DJ
Beardsley, C
Anderson, H
Wallace, P
Smith, G
Howard, S
Dreyer, RF
Ma, C
Chenoweth, RG
Zilis, JD
Johnson, M
[J]. ARCHIVES OF OPHTHALMOLOGY, 2001, 119 (10) : 1417 - 1436
[7] KLEIN R, 1992, OPHTHALMOLOGY, V99, P933
[8] From bench to FDA to bedside: US regulatory trends for new stem cell therapies
Knoepfler, Paul S.
[J]. ADVANCED DRUG DELIVERY REVIEWS, 2015, 82-83 : 192 - 196
[9] Sources of retinal pigment epithelium (RPE) for replacement therapy
Lee, E.
MacLaren, R. E.
[J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2011, 95 (04) : 445 - 449
[10] In vitro Differentiation of Adult Adipose Mesenchymal Stem Cells into Retinal Progenitor Cells
Moviglia, Gustavo A.
Blasetti, Nahuel
Zarate, Jorge O.
Pelayes, David E.
[J]. OPHTHALMIC RESEARCH, 2012, 48 : 1 - 5

← 1 2 3 →